Fashion
-
ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive WorkflowDetails
The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro,extending ZEISS\' LVC market leadership with treatment for myopia,hyperopia,and mixed astigmatism.
-
Gianna Lullume Baby Soother Device Officially Launches on KickstarterDetails
HONG KONG,Jan. 13,2025-- Gianna Lullume,an innovative brand committed to improving infant sleep and promoting family well-being,is proud to announce the official launch of its crowdfunding campaign on
-
Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology PlatformDetails
MELBOURNE,Australiaand INDIANAPOLIS,Jan. 13,2025-- Telix Pharmaceuticals Limited (ASX: TLX,Nasdaq: TLX,Telix,the Company) today announces it has entered into an asset purchase agreement with antibody
-
MLVision M5 Unveiled at CES 2025: Pioneering Innovation in Wearable Technology with the World's Lightest AI-Powered AR GlassesDetails
LAS VEGAS,Jan. 11,2025-- AtCES 2025,MLVision has officially launched its groundbreaking MLVision M5,setting a new global standard for wearable technology. Weighing a mere 25.8 grams,the MLVision M5 is
-
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in OncologyDetails
This is the second asset Menarini Group has inlicensed from Insilico Medicine which was discovered through their generative AI platform,similar to the preclinical stage KAT6 inhibitor (MEN2312) licens
-
Sciwind Biosciences Announces Global Licensing and Collaboration Agreement for Metabolic Disease PortfolioDetails
HANGZHOU,China,Jan. 10,2025--HangzhouSciwind Biosciences Co.,a pre-commercial biopharmaceutical company focusing on developing innovative therapies to treat metabolic diseases,today announced a licens
-
SN BioScience Propels SNB-101 to Phase 2 with IND Clearance from FDADetails
SEOUL,South Korea,Jan. 10,2025-- SNBioScience today announced that its lead asset SNB-101 has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for a
-
NAVEE Launches ST3 Pro and GT3 Pro at CES 2025, Receives UL and TÜV Rheinland CertificationsDetails
LAS VEGAS,Jan. 10,2025-- NAVEE,a global leader in intelligent short-distance mobility,today announced the North American launch of its flagship electric scooters,ST3 Pro and GT3 Pro,at CES 2025. The e
-
XbotPark Showcases Over 30 Incubated Hardware Startups at CES 2025Details
LAS VEGAS,Jan. 9,2025-- XbotPark,a leading startup incubator specializing in robotics and smart hardware,debuted over 30 incubated startups and its supply chain platform at CES 2025. This milestone de
-
BOE shines at CES 2025 with cutting-edge technologies, leveraging the "HERO" Initiative to unlock a smarter future across diverse scenariosDetails
LAS VEGAS,Jan. 9,2025-- Held in Las Vegas,the United States from January 7 to 10,the Consumer Electronics Show 2025 (CES 2025) stands as a barometer of the global consumer electronics market. Chinese